| | Class 2 Device Recall Flowflex SARSCoV2 Antigen Rapid Test (SelfTesting), CE marked |  |
| Date Initiated by Firm | January 09, 2022 |
| Create Date | April 15, 2022 |
| Recall Status1 |
Open3, Classified |
| Recall Number | Z-0945-2022 |
| Recall Event ID |
89755 |
| Product Classification |
Coronavirus antigen detection test system. - Product Code QKP
|
| Product | Flowflex SARS-CoV-2 Antigen Rapid Test (Self-Testing), CE marked |
| Code Information |
Lots: COV1080201, COV1105014 |
| FEI Number |
3002829675
|
Recalling Firm/ Manufacturer |
Acon Biotech (Hangzhou) Co., Ltd. 398 Tianmushan Road Hangzhou China
|
| For Additional Information Contact | 011 86 858 200 |
Manufacturer Reason for Recall | Non-EUA authorized, CE marked, SARS-CoV-2 antigen rapid test kits are being recalled from the U.S. market because use may lead to inaccurate test results, including false negative or false positive test results. |
FDA Determined Cause 2 | No Marketing Application |
| Action | On 04/04/22, recall notices were sent to distributor customers who were asked to do the following:
If you may have further distributed this product, please identify your customers and notify them at once of this product correction. Your notification to your customers may be enhanced by including a copy of this correction notification letter. This correction should be carried out to the consumer/user level in U.S. Complete and return the response form to the recalling firm.
Customers with additional questions were encouraged to contact Denice Dong, Denice.Dong@aconlab.com.cn
Additional instructions in a press release were provided to address affected non-EUA devices, of unknown quantity, that may have entered the U.S. market. It is recommended to stop use and dispose of affected devices in the U.S. market: https://www.aconlabs.com/news/
|
| Quantity in Commerce | 303,760 |
| Distribution | US: MD, PA
International Distribution to countries of: Hungary and China. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
|
|
|